knowledge -WSS

knowledge

author：explore 2025-09-29 16:34:31 - browse：11934

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： The world needs the new pandemic treaty

hotspot

WSS

10 reasons why health care startups fail

Decentralized clinical trials need collaboration to achieve wider use

Pharma’s losing bet in New Jersey

Decentralized clinical trials need collaboration to achieve wider use

Why you shouldn’t ask, “What country has the best health care?”

Humana’s losses in Medicare Advantage tank its stock

explore

knowledge

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

10 reasons why health care startups fail

Supreme Court strikes down use of affirmative action

Merck, Johnson & Johnson CEOs will testify on high drug prices

How one medical school became remarkably diverse

Medicare drug price negotiation legal challenge met with skepticism

Hollywood unions extend contract negotiations for actors

Merck CEO won’t testify in Senate, citing no expertise in drug prices

New air purifier tech could be key to improving indoor air quality

Louisiana bill approved classifying abortion pills as controlled substances

hotspot

Decentralized clinical trials need collaboration to achieve wider use

Should insurance cover cosmetic surgery?

Reconstructing family trees of blood cells may help predict disease

Pharma’s losing bet in New Jersey

Venture capital firm's plans to take over Akron hospital face hurdles

Wegovy leads to weight loss. Can it treat depression, too?

focus

hotspot

Wikipedia

leisure time